Regenerative Medicine
Humacyte news and milestones
Humacyte: 10 headlines on record, 5 headlines in the last 90 days. Its story counts 4 milestones.
Data updated Nov 18, 2026 · Back to the company report
10Headlines
5In 90 days
4Milestones
Headlines
Oct 92026
News · YahooFinance
Price targets on Humacyte have shifted lower, with one analyst setting a US$0.50 target and another cutting a target to US$1, while modeled fair value has moved from about US$2.0…
Oct 72026
Oct 72026
Oct 72026
News · YahooFinance
Humacyte, Inc. (HUMA) concluded the recent trading session at $0.48, signifying a -4.26% move from its prior day
Sep 282026
News · marketscreener.com
Oct 14, 20252025
Press release · newswire.com
On October 7, 2025, Humacyte, Inc. (Nasdaq:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioenginee ...
Mar 24, 20252025
News · seekingalpha.com
Feb 25, 20252025
News · nasdaq.com
Nov 5, 20242024
News · nasdaq.com
Jul 22, 20242024
News · seekingalpha.com
Sources: the outlets named on each headline, each story once
Milestones
Oct 2026
Went public NASDAQ: HUMA
Jun 25, 2018
Feb 23, 2018
Each milestone is dated by its source: registers, filings, the press
How to cite
Humacyte, News. Alion, Nov 18, 2026. https://alion.io/company/humacyte/news
